100 related articles for article (PubMed ID: 28086757)
1. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S
BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the sonic hedgehog pathway cause macrocephaly-associated conditions due to crosstalk to the PI3K/AKT/mTOR pathway.
Klein SD; Nguyen DC; Bhakta V; Wong D; Chang VY; Davidson TB; Martinez-Agosto JA
Am J Med Genet A; 2019 Dec; 179(12):2517-2531. PubMed ID: 31639285
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.
Adamo B; Deal AM; Burrows E; Geradts J; Hamilton E; Blackwell KL; Livasy C; Fritchie K; Prat A; Harrell JC; Ewend MG; Carey LA; Miller CR; Anders CK
Breast Cancer Res; 2011; 13(6):R125. PubMed ID: 22132754
[TBL] [Abstract][Full Text] [Related]
4. Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.
Renard E; Bonnet C; Di Patrizio M; Schmitt E; Madkaud AC; Chabot C; Kuchenbuch M; Lambert L
Am J Med Genet A; 2024 Jul; 194(7):e63585. PubMed ID: 38459620
[TBL] [Abstract][Full Text] [Related]
5. Prenatal Ultrasound Diagnosis of Megalencephaly-Polymicrogyria-Polydactyly-Hydrocephalus Syndrome with Persistent Hyperplastic Primary Vitreous: A Case Report.
Su XR; Ma B; Zhang C; Li TG; Han BL; Wu WR; Nie F
Fetal Diagn Ther; 2024; 51(2):154-158. PubMed ID: 38008077
[TBL] [Abstract][Full Text] [Related]
6. A
Zhao MF; Zhang SL; Xiang Y; Wang Q; Cao GH; Zhang PP; Fan LL; Yu R; Li YL
DNA Cell Biol; 2024 May; ():. PubMed ID: 38700464
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function MYCN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
[TBL] [Abstract][Full Text] [Related]
8. A spectrum of AKT3 activating mutations cause focal malformations of cortical development (FMCDs) in cortical organoids.
Xu Y; Lu R; Li H; Feng W; Zhao R
Biochim Biophys Acta Mol Basis Dis; 2024 May; 1870(6):167232. PubMed ID: 38759814
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.
Yeung KS; Tso WWY; Ip JJK; Mak CCY; Leung GKC; Tsang MHY; Ying D; Pei SLC; Lee SL; Yang W; Chung BH
Mol Autism; 2017; 8():66. PubMed ID: 29296277
[TBL] [Abstract][Full Text] [Related]
10. Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
Alcantara D; Timms AE; Gripp K; Baker L; Park K; Collins S; Cheng C; Stewart F; Mehta SG; Saggar A; Sztriha L; Zombor M; Caluseriu O; Mesterman R; Van Allen MI; Jacquinet A; Ygberg S; Bernstein JA; Wenger AM; Guturu H; Bejerano G; Gomez-Ospina N; Lehman A; Alfei E; Pantaleoni C; Conti V; Guerrini R; Moog U; Graham JM; Hevner R; Dobyns WB; O'Driscoll M; Mirzaa GM
Brain; 2017 Oct; 140(10):2610-2622. PubMed ID: 28969385
[TBL] [Abstract][Full Text] [Related]
11. PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes.
Shi X; Lim Y; Myers AK; Stallings BL; Mccoy A; Zeiger J; Scheck J; Cho G; Marsh ED; Mirzaa GM; Tao T; Golden JA
Ann Neurol; 2020 Dec; 88(6):1077-1094. PubMed ID: 32856318
[TBL] [Abstract][Full Text] [Related]
12. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
[TBL] [Abstract][Full Text] [Related]
13. Megalencephaly syndromes associated with mutations of core components of the PI3K-AKT-MTOR pathway: PIK3CA, PIK3R2, AKT3, and MTOR.
Dobyns WB; Mirzaa GM
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):582-590. PubMed ID: 31441589
[TBL] [Abstract][Full Text] [Related]
14. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
Gerasimenko A; Baldassari S; Baulac S
Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
[TBL] [Abstract][Full Text] [Related]
15. The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2.
Lai A; Soucy A; El Achkar CM; Barkovich AJ; Cao Y; DiStefano M; Evenson M; Guerrini R; Knight D; Lee YS; Mefford HC; Miller DT; Mirzaa G; Mochida G; Rodan LH; Patel M; Smith L; Spencer S; Walsh CA; Yang E; Yuskaitis CJ; Yu T; Poduri A;
Genet Med; 2022 Nov; 24(11):2240-2248. PubMed ID: 35997716
[TBL] [Abstract][Full Text] [Related]
16. Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability.
Reijnders MRF; Kousi M; van Woerden GM; Klein M; Bralten J; Mancini GMS; van Essen T; Proietti-Onori M; Smeets EEJ; van Gastel M; Stegmann APA; Stevens SJC; Lelieveld SH; Gilissen C; Pfundt R; Tan PL; Kleefstra T; Franke B; Elgersma Y; Katsanis N; Brunner HG
Nat Commun; 2017 Oct; 8(1):1052. PubMed ID: 29051493
[TBL] [Abstract][Full Text] [Related]
17. Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.
Leiter SM; Parker VER; Welters A; Knox R; Rocha N; Clark G; Payne F; Lotta L; Harris J; Guerrero-Fernández J; González-Casado I; García-Miñaur S; Gordo G; Wareham N; Martínez-Glez V; Allison M; O'Rahilly S; Barroso I; Meissner T; Davies S; Hussain K; Temple K; Barreda-Bonis AC; Kummer S; Semple RK
Eur J Endocrinol; 2017 Aug; 177(2):175-186. PubMed ID: 28566443
[TBL] [Abstract][Full Text] [Related]
18. Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes.
Levitin MO; Rawlins LE; Sanchez-Andrade G; Arshad OA; Collins SC; Sawiak SJ; Iffland PH; Andersson MHL; Bupp C; Cambridge EL; Coomber EL; Ellis I; Herkert JC; Ironfield H; Jory L; Kretz PF; Kant SG; Neaverson A; Nibbeling E; Rowley C; Relton E; Sanderson M; Scott EM; Stewart H; Shuen AY; Schreiber J; Tuck L; Tonks J; Terkelsen T; van Ravenswaaij-Arts C; Vasudevan P; Wenger O; Wright M; Day A; Hunter A; Patel M; Lelliott CJ; Crino PB; Yalcin B; Crosby AH; Baple EL; Logan DW; Hurles ME; Gerety SS
Brain; 2023 Nov; 146(11):4766-4783. PubMed ID: 37437211
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and psychological features of PTEN mutations: a systematic review of the literature and meta-analysis of the prevalence of autism spectrum disorder characteristics.
Cummings K; Watkins A; Jones C; Dias R; Welham A
J Neurodev Disord; 2022 Jan; 14(1):1. PubMed ID: 34983360
[TBL] [Abstract][Full Text] [Related]
20. Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.
Pirozzi F; Lee B; Horsley N; Burkardt DD; Dobyns WB; Graham JM; Dentici ML; Cesario C; Schallner J; Porrmann J; Di Donato N; Sanchez-Lara PA; Mirzaa GM
Am J Med Genet A; 2021 Sep; 185(9):2719-2738. PubMed ID: 34087052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
